Veterinary Guidelines for Managing Diabetes in Cats
Veterinarians emphasize the importance of careful patient selection and safety considerations when deciding between insulin and SGLT2 inhibitors for cats newly diagnosed with diabetes.


When a newly diabetic cat is first seen by a veterinarian, the decision between using insulin and an SGLT2 inhibitor is primarily based on safety and patient selection, according to Kelly Cairns, DVM, MS, DACVIM (SAIM). The choice is not influenced by the ease of administration for the client, but rather by specific medical criteria that must be met (1). [1]
Currently, two SGLT2 inhibitors are available for use in cats: Bexacat (bexagliflozin) and Senvelgo (velagliflozin oral solution), which come in both liquid and tablet forms. These drugs are contraindicated in cats that have ever received insulin, are currently receiving insulin, or have insulin-dependent diabetes. Veterinarians should not discontinue insulin therapy in favor of an SGLT2 inhibitor (1). [1]
Additionally, SGLT2 inhibitors are not recommended for sick cats that are clinically anorectic, dehydrated, lethargic, or ketotic. If a cat is vomiting or has comorbidities, a thorough assessment—including checking for ketones and beta-hydroxybutyrate levels—is necessary. Kidney and liver function must also be evaluated, as both drugs carry warnings or contraindications in the presence of these conditions (1). [1]
When a newly diabetic cat is first seen by a veterinarian, the decision between using insulin and an SGLT2 inhibitor is primarily based on safety and patient selection, according to Kelly Cairns, DVM, MS, DACVIM (SAIM) (1). Currently, two SGLT2 inhibitors are available for use in cats: Bexacat (bexagliflozin) and Senvelgo (velagliflozin oral solution), which come in both liquid and tablet forms (1). [1]
Advertisement
SGLT2 inhibitors are not recommended for sick cats that are clinically anorectic, dehydrated, lethargic, or ketotic (1). Veterinarians must carefully evaluate the cat's overall health before prescribing these drugs, as they are contraindicated in cats that have ever received insulin, who are receiving insulin now, or have insulin-dependent diabetes (1). [1]
Additionally, if a cat is vomiting or has comorbidities, an assessment is necessary, including checking for ketones and beta-hydroxybutyrate (1). Veterinarians must also ensure that the kidney function and the liver function are normal, as both drugs have warnings or overt contraindications in the setting of those diseases, as well as other comorbidities (1). [1]
When a newly diabetic cat is first seen by a veterinarian, the decision between using insulin and an SGLT2 inhibitor is primarily based on safety and patient selection, according to Kelly Cairns, DVM, MS, DACVIM (SAIM) (1). This approach ensures that the treatment is appropriate for the individual cat's condition and health status. [1]
SGLT2 inhibitors are not recommended for sick cats that are clinically anorectic, dehydrated, lethargic, or ketotic (1). These drugs are contraindicated in cats that have ever received insulin, are currently receiving insulin, or have insulin-dependent diabetes. It is important not to discontinue insulin in favor of an SGLT2 inhibitor without careful evaluation. [1]
Advertisement
If a cat is vomiting or has comorbidities, an assessment is necessary, including checking for ketones and beta-hydroxybutyrate (1). Additionally, it is important to ensure that kidney and liver functions are normal, as both drugs have warnings or overt contraindications in the setting of those diseases and other comorbidities. [1]
The decision to use SGLT2 inhibitors in newly diabetic cats is primarily guided by safety and patient selection, as noted by Kelly Cairns, DVM, MS, DACVIM (SAIM), in an article from dvm360 (1). Two SGLT2 inhibitors, Bexacat (bexagliflozin) and Senvelgo (velagliflozin oral solution), are available in both liquid and tablet forms. However, these drugs are contraindicated for cats that have ever received insulin, are currently on insulin, or have insulin-dependent diabetes. Veterinarians should not discontinue insulin to switch a cat to an SGLT2 inhibitor (1). [1]
SGLT2 inhibitors are not recommended for sick cats that are clinically anorectic, dehydrated, lethargic, or ketotic, according to the same source (1). In cases where a cat is vomiting or has comorbidities, a thorough assessment is necessary, including checking for ketones and beta-hydroxybutyrate. This evaluation helps determine the appropriateness of SGLT2 inhibitors for the individual cat (1). [1]
Before prescribing SGLT2 inhibitors, it is essential to ensure that the cat's kidney and liver functions are within normal ranges, as both drugs have warnings or contraindications related to these conditions. The use of these medications should be strictly on label to ensure safety and effectiveness (1). [1]
Advertisement
The Cali Reporter newsletter
The stories worth your time.
California, the country, and what comes next. Join our free newsletter for reporting that keeps you informed.
More in Pets & Animals
- Toxoplasmosis in Dogs: New Ocular Manifestations and Diagnostic Challenges
A recent case series highlights the underrecognized role of Toxoplasma gondii in causing ocular inflammation in dogs, with findings that challenge previous assumptions about the disease's prevalence and presentation in…
- Regional Variations in Allergic Dermatitis Seasons
Allergic dermatitis in dogs is influenced by regional allergen patterns, with variations in allergy seasons across different parts of the country. This affects how veterinary care is managed and prepared for by general…
- Feline Patient Receives Complex Surgery for Pituitary Tumor
A 10-year-old cat from Hoboken, New Jersey, underwent a complex surgical procedure in Oregon to remove a pituitary tumor that caused severe insulin resistance.